Author: admin

  • Andrew Stephenson – 2016 Parliamentary Question to the Department of Health

    Andrew Stephenson – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Stephenson on 2016-09-02.

    To ask the Secretary of State for Health, whether any NHS bodies offer advice to parents that electrical safety socket covers or inserts should be installed in the home.

    Mr Philip Dunne

    On 30 June 2016 the Department issued an Estates and Facilities Alert (EFA) 2016/002 advising that electrical socket inserts should be removed from all premises where National Health Service care is delivered. The alert also advises NHS organisations against providing electrical socket inserts for use in the home. The safety Alert can be found at the following link:

    https://www.cas.dh.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=102494

    “

  • Caroline Lucas – 2016 Parliamentary Question to the Department of Health

    Caroline Lucas – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Caroline Lucas on 2016-09-02.

    To ask the Secretary of State for Health, pursuant to the Answer of 6 July 2016 to Question 41361, on NHS Professionals, which potential options his Department has been exploring.

    Mr Philip Dunne

    No decisions have yet been taken by Ministers on the future of NHS Professionals.

  • Andrew Bridgen – 2016 Parliamentary Question to the Department of Health

    Andrew Bridgen – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Bridgen on 2016-09-02.

    To ask the Secretary of State for Health, what measures his Department has in place to ensure that children with cerebral palsy in rural areas are able to access the services they require.

    David Mowat

    Clinical commissioning groups (CCGs) are responsible for commissioning universal health services for their area that meet the needs of their local population. In doing so they should take account of best practice such as that set out in the National Institute for Health and Care Excellence (NICE) guidelines. Funding for CCGs is allocated by NHS England using an agreed formula.

    Paediatric neurology services are provided in both out and in-patient settings. The majority of these are specialised services commissioned directly by NHS England. These specialised services are based in Neurosciences Centres which have the necessary infrastructure in terms of diagnostic services and other specialities. However, paediatric neurology provides out-patient services based in secondary care centres around the geographical region served. This allows specialist services to be provided as near to patients as is reasonably feasible

    When considering what services should be commissioned we expect commissioners to take account of best practice and guidance and, where appropriate, the local Joint Strategic Needs Assessment, and Joint Health and Wellbeing Strategy, which captures local need.

    The Department has asked NICE to develop guidance on cerebral palsy. The guideline, Cerebral palsy: diagnosis and management in children and young people under 25 is currently open for consultation and is expected to be published in January 2017. Guidance for adults is also being developed and is expected to be published in 2019.

  • Andrew Bridgen – 2016 Parliamentary Question to the Department of Health

    Andrew Bridgen – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Bridgen on 2016-09-02.

    To ask the Secretary of State for Health, whether his Department plans to make additional funds available to areas where specialist cerebral palsy facilities are not currently available.

    David Mowat

    Clinical commissioning groups (CCGs) are responsible for commissioning universal health services for their area that meet the needs of their local population. In doing so they should take account of best practice such as that set out in the National Institute for Health and Care Excellence (NICE) guidelines. Funding for CCGs is allocated by NHS England using an agreed formula.

    Paediatric neurology services are provided in both out and in-patient settings. The majority of these are specialised services commissioned directly by NHS England. These specialised services are based in Neurosciences Centres which have the necessary infrastructure in terms of diagnostic services and other specialities. However, paediatric neurology provides out-patient services based in secondary care centres around the geographical region served. This allows specialist services to be provided as near to patients as is reasonably feasible

    When considering what services should be commissioned we expect commissioners to take account of best practice and guidance and, where appropriate, the local Joint Strategic Needs Assessment, and Joint Health and Wellbeing Strategy, which captures local need.

    The Department has asked NICE to develop guidance on cerebral palsy. The guideline, Cerebral palsy: diagnosis and management in children and young people under 25 is currently open for consultation and is expected to be published in January 2017. Guidance for adults is also being developed and is expected to be published in 2019.

  • Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Barry Sheerman on 2016-09-02.

    To ask the Secretary of State for Health, what estimate his Department has made of the financial saving to the NHS of the policy to no longer routinely fund second stem cell transplants for blood cancer patients who have relapsed.

    David Mowat

    Decisions are taken by NHS England’s Specialised Commissioning Oversight Group that leads on the annual prioritisation process. The prioritisation process includes an impact assessment that compared the cost of a second transplant to alternative treatment pathways for relapsed disease.

  • Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Barry Sheerman on 2016-09-02.

    To ask the Secretary of State for Health, what estimate his Department has made of the number of relapsed blood cancer patients who will no longer be able to access second stem cell transplants as a result of the NHS England decision published on 11 July 2016 to no longer routinely fund second stem cell transplants for those patients.

    David Mowat

    The Clinical Priorities Advisory Group which makes recommendations to the Specialised Commissioning Oversight Group uses a defined process to prioritise treatments based on a combination of cost and patient benefit. The process includes an impact assessment that estimated that up to 22 patients per year by 2021 might be affected by this decision.

  • Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Barry Sheerman on 2016-09-02.

    To ask the Secretary of State for Health, what recent discussions he has had with NHS England on the allocation of funding for second stem cell transplants.

    David Mowat

    My Rt. hon. Friend the Secretary of State has not had any discussions related to the allocation of funding for second stem cell transplants.

    NHS England has announced that the second stem cell transplants will be included as part of a re-run of the prioritisation process by the Specialised Commissioning Oversight Group to be completed later this year.

  • Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    Barry Sheerman – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Barry Sheerman on 2016-09-02.

    To ask the Secretary of State for Health, what recent representations he has received from charities and health experts on the allocation of funding for second stem cell transplants.

    David Mowat

    The Department has received representations from a range of individuals and organisations including the charity Anthony Nolan.

  • Stephen McPartland – 2016 Parliamentary Question to the Department of Health

    Stephen McPartland – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Stephen McPartland on 2016-09-02.

    To ask the Secretary of State for Health, what the average cost of a liver transplant was in the last year.

    Nicola Blackwood

    NHS England advises that the overall cost of operations for 2015-16 is currently being finalised. However, based on 2014-15 financial information, the average cost per operation in that year was £67,131.

    These figures are for the United Kingdom as liver transplantation is a service that NHS England commissions on behalf of England and the three devolved nations.

  • Stephen McPartland – 2016 Parliamentary Question to the Department of Health

    Stephen McPartland – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Stephen McPartland on 2016-09-02.

    To ask the Secretary of State for Health, what discussions officials of his Department have had with their counterparts in (a) Wales on the Welsh Liver Disease Delivery Plan and (b) Scotland on the Sexual Health and Blood Borne Virus Framework.

    David Mowat

    There have been no discussions with counterparts in Wales on the Welsh Liver Disease Delivery Plan or Scotland on the Sexual Health and Blood Borne Virus Framework.

    Public Health England contributes to the Lancet Commission on Liver Disease and the Lancet Commission have also reviewed the Welsh Liver Disease Delivery Plan.